This inventor holds 1 USPTO granted patent. Top assignee: Koninklijke Philips Corporation N.v.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: David M Pettigrew: Innovator in Microfluidic Technology
Introduction
David M Pettigrew is a notable inventor based in Eindhoven, GB. He has made significant contributions to the field of microfluidics, particularly with his innovative designs that enhance blood analysis. His work is instrumental in advancing medical diagnostics and improving patient care.
Latest Patents
David M Pettigrew holds a patent for a microfluidic device designed for full blood count analysis. This device features a first channel and a second channel that are separated from each other. It includes a first inlet that provides a whole blood sample to both channels, a second inlet for a lysis agent aimed at white blood cell count in the first channel, a third inlet for a quench solution in the first channel, and a fourth inlet for a lysis agent intended for hemoglobin measurement in the second channel. This innovative approach allows for more efficient and accurate blood testing.
Career Highlights
David is currently employed at Koninklijke Philips Corporation N.V., where he continues to develop cutting-edge technologies in the medical field. His work at Philips has allowed him to collaborate with other experts and contribute to significant advancements in healthcare technology.
Collaborations
David M Pettigrew has worked alongside his coworker, James Donald Gwyer, to further enhance the capabilities of their projects. Their collaboration has been vital in pushing the boundaries of what is possible in microfluidic devices.
Conclusion
David M Pettigrew is a pioneering inventor whose work in microfluidic technology is shaping the future of medical diagnostics. His contributions are essential for improving the accuracy and efficiency of blood analysis, ultimately benefiting patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
